Mettler-Toledo International (NYSE:MTD) Price Target Raised to $1,400.00

Mettler-Toledo International (NYSE:MTD) had its price objective lifted by Evercore ISI from $1,275.00 to $1,400.00 in a research note issued to investors on Tuesday,Benzinga reports. They currently have an outperform rating on the medical instruments supplier’s stock.

A number of other equities analysts have also issued reports on the stock. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Mettler-Toledo International in a research report on Saturday, September 27th. Citigroup boosted their price target on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a “buy” rating in a report on Thursday, August 21st. Bank of America boosted their price target on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a report on Monday, September 22nd. Robert W. Baird boosted their price target on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a “neutral” rating in a report on Monday, August 4th. Finally, Barclays boosted their price target on shares of Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the company an “overweight” rating in a report on Thursday, October 2nd. Five analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $1,336.50.

Mettler-Toledo International Trading Down 1.5%

Shares of MTD stock opened at $1,307.98 on Tuesday. Mettler-Toledo International has a 1 year low of $946.69 and a 1 year high of $1,486.76. The firm’s fifty day simple moving average is $1,277.46 and its 200 day simple moving average is $1,189.50. The firm has a market capitalization of $26.94 billion, a P/E ratio of 33.12, a price-to-earnings-growth ratio of 3.99 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The business had revenue of $983.22 million for the quarter, compared to analyst estimates of $957.41 million. During the same quarter in the previous year, the firm posted $9.65 earnings per share. Mettler-Toledo International’s revenue was up 3.9% compared to the same quarter last year. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Equities research analysts anticipate that Mettler-Toledo International will post 42.71 EPS for the current fiscal year.

Insider Buying and Selling

In related news, insider Gerry Keller sold 165 shares of the company’s stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the transaction, the insider owned 94 shares in the company, valued at $123,012.16. This represents a 63.71% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Shawn Vadala sold 300 shares of the company’s stock in a transaction dated Friday, August 8th. The stock was sold at an average price of $1,254.09, for a total transaction of $376,227.00. Following the transaction, the chief financial officer owned 5,095 shares in the company, valued at approximately $6,389,588.55. This trade represents a 5.56% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 1,827 shares of company stock worth $2,371,208 in the last 90 days. Corporate insiders own 1.94% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in MTD. GAMMA Investing LLC grew its stake in shares of Mettler-Toledo International by 1.6% during the 3rd quarter. GAMMA Investing LLC now owns 510 shares of the medical instruments supplier’s stock worth $626,000 after acquiring an additional 8 shares in the last quarter. Greenleaf Trust grew its stake in shares of Mettler-Toledo International by 1.2% during the 1st quarter. Greenleaf Trust now owns 872 shares of the medical instruments supplier’s stock worth $1,030,000 after acquiring an additional 10 shares in the last quarter. Brooklyn Investment Group grew its stake in shares of Mettler-Toledo International by 12.8% during the 1st quarter. Brooklyn Investment Group now owns 88 shares of the medical instruments supplier’s stock worth $104,000 after acquiring an additional 10 shares in the last quarter. Sax Wealth Advisors LLC grew its stake in shares of Mettler-Toledo International by 2.8% during the 2nd quarter. Sax Wealth Advisors LLC now owns 372 shares of the medical instruments supplier’s stock worth $437,000 after acquiring an additional 10 shares in the last quarter. Finally, Benjamin Edwards Inc. grew its stake in shares of Mettler-Toledo International by 4.8% during the 2nd quarter. Benjamin Edwards Inc. now owns 218 shares of the medical instruments supplier’s stock worth $256,000 after acquiring an additional 10 shares in the last quarter. 95.07% of the stock is currently owned by institutional investors and hedge funds.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.